Ibuprofen augments gastrointestinal symptoms in lactose maldigesters during a lactose tolerance test

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 9, 1999, Pages 1227-1233

  Peuhkuri, K ^a,b   Nevala, R ^a   Vapaatalo, H ^a   Moilanen, H ^c,d   Korpela, Riitta ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOUNDATION FOR NUTRITION RESEARCH   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLIC GMP; IBUPROFEN; LACTOSE; NITRATE; NITRIC OXIDE; NITRITE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTANOID; SUCROSE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LACTOSE INTOLERANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; LACTOSE INTOLERANCE; LACTOSE TOLERANCE TEST; MALE; MIDDLE AGED; PROSTAGLANDINS;

EID: 0032848861     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00608.x     Document Type: Article

References (27)

1. Viliako K, Maaroos H. Clinical picture or hypolactasia and lactose intolerance. Scand J Gastroenterol 1994; 29(Suppl. 202): 36-54.
2. Drossman DA, Richter JE, Talley NJ. et al. Functional gastrointestinal disorders: diagnosis, pathophysiology and treatment. Boston: Little Brown, 1994: 1-370.
3. Rask-Madsen J. Eicosanoids and their role in the pathogenesis of diarrhoeal disease. Clin Gastroenterol 1986; 15: 545-66.
4. Stark ME, Szurszewski JH. Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 1992; 103: 1928-49.
5. Lefebvre RA, Smits GJM, Timmermans J-P. Study of NO and VIP as non-adrenergic non-cholinergic neurotransmitters in the pig gastric fundus. Br J Pharmacol 1995; 116: 2017-26.
6. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996; 25: 1106-15.
7. Henry D, Lim LL-Y, Rodriques LAG, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. Br Med J 1996; 312: 1563-6.
8. Pcuhkuri K, Vapaatalo H, Nevala R, et al. Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms. Alim Pharmacol Ther 1999; 13: 81-6.
9. Tcuri U, Vapaatalo H, Korpela R. Fructo-oligosaccharides and lactulose cause more symptoms in lactose maldigesters and pseudohypolactasia subjects than in control digesters. Am J Clin Nutr 1999; 69: 973-9.
10. 2 for diagnosing hypolactasia. Scand J Gin Lab Invest 1998; 58: 217-24.
11. Axelsson KL, Bornefelt KE, Norlander B, et al. Attomole-sensitive radioimmunoassay for cyclic GMP. Second Mess Phosphoprot 1988; 12: 145-54.
12. Buissert PD, Heinzelmann DI, Youlten LJF, et al. Prostaglandin-synthesis inhibitors in prophylaxis of food intolerance. Lancet 1978; 1: 906-7.
13. Flatz G, Lie GH. Effect of acetylsalicylic acid on symptoms and hydrogen excretion in the disaccharide tolerance test with lactose or lactulose. Am J Clin Nutr 1982; 35: 273-6.
14. O'Loughlin EV, Scott RB, Gall DG. Pathophysiology of infectious diarrhea: Changes in intestinal structure and function. J Pediatr Gastroenterol Nutr 1991; 12: 5-20.
15. Thor P, Konturek JW, Konturek SJ, et al. Role of prostaglandins in control of intestinal motility. Am J Physiol 1985; 248: G353-G359.
16. Stein J, Zeuzem S, Uphoff K, et al. Effects of prostaglandins and indomethacin on gastric emptying in the rat. Prostaglandins 1994; 47: 11-40.
17. Dubois A, Conclin JJ. Prostaglandins and gastric emptying. Adv Prost Throm Leuk Res 1987; 17: 370-2.
18. Corac A, Coskun T, Alican T, et al. The effect of nitric oxide synthase blockade and indomethacin on gastric emptying and gastric contractility. Pharmacology 1997; 54: 298-394.
19. Chaudhuri TK, Fink S. Lack of effect of indomethacin on gastric emptying in old men. J Am Ger Soc 1984; 32: 19-20.
20. Rinetti M, Ugolotti G, Calbiani B. et al. Anti-inflammatory drugs and gastric emptying. A comparison between acetylsalicylic acid and carprofen. Arzeim Forsch/Drug Research 1982; 32; 1561-3.
21. Keshagias S, Jönsson KÅ, Norlander B, et al. Low-dose aspirin decreases blood alcohol concentrations by delaying gastric emptying. Eur J Clin Pharmacol 1997; 53: 241-6.
22. Donnelly MT, Hawkey CJ. Review article: COX-II inhibitors - a new generation of safer NSAIDs? Aliment Pharmacol Ther 1997; 11: 227-36.
23. Lipsky PE, Isakson PC. Outcome of specific COX-2 inhibition in rheumatoid arthritis. J Rheumatol 1997 (Suppl. 49) 24: 9-14.
24. Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 338-40.
25. Rachmilewitz D, Stamler JS, Bachwich D, et al. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 718-23.
26. Mourelle M, Casellas F, Guarner F, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995; 109: 1497-502.
27. Wennmalm Å. Metabolism and excretions of nitric oxide in man: Basal studies und clinical applications. Agents Actions 1995 (Suppl. 45): 129-38.